Chronic Pancreatitis. Effect of Pioglitazone on Endocrine Function, Exocrine Function & Structure, Pain & Life Quality

Completed · Phase 2 · Has a placebo group

Conditions studied: Chronic Pancreatitis, Insulin Resistance, Normal or Mildly Abnormal Stool Fat Levels

In brief

The purpose of this study is to determine if study drug (Pioglitazone) treatment will improve pre-diabetes (insulin resistance) or ealy diabetes and improve clinical symptoms (pain) or laboratory evidence of chronic pancreatitis. The goal of the investigators is to gather information from this study to help gain understanding of a potential therapy for chronic pancreatitis.

Key facts

Study ID
NCT00782795
Run by
University of Michigan
People needed
64
Starts
2008-11-01
Expected to finish
2013-12-01
Last updated by the study team
2018-01-11

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.